The isolated muscle fibre as a model of disuse atrophy: Characterization using PhAct, a method to quantify f-actin

Experimental Cell Research

Volumn 317, Issue 14, 2011, Pages 1979-1993

  Duddy, William J ^a   Cohen, Tatiana ^a   Duguez, Stephanie ^a   Partridge, Terence A ^a  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Follistatin; Muscle atrophy; Myoblast; Myofibre; Myonucleus; Myostatin

Indexed keywords

ACTIN; F ACTIN; FOLLISTATIN; LEUCINE; MYOSTATIN; NUCLEOTIDE DERIVATIVE; PHALLOIDIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL NUCLEUS; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; EX VIVO STUDY; GENE EXPRESSION; MICROSCOPY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE MASS; NONHUMAN; PHALLOIDIN BASED ACTIN QUANTIFICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 79960095513     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.05.013     Document Type: Article

References (79)

1. Bekoff A., Betz W.J. Physiological properties of dissociated muscle fibres obtained from innervated and denervated adult rat muscle. J. Physiol. 1977, 271:25-40.
2. Bekoff A., Betz W. Properties of isolated adult rat muscle fibres maintained in tissue culture. J. Physiol. 1977, 271:537-547.
3. Rosenblatt J.D., Lunt A.I., Parry D.J., Partridge T.A. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev. Biol. Anim. 1995, 31:773-779.
4. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., Morgan J.E. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005, 122:289-301.
5. Tisdale M.J. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J. Support. Oncol. 2005, 3:209-217.
6. Hinkle R.T., Donnelly E., Cody D.B., Bauer M.B., Isfort R.J. Urocortin II treatment reduces skeletal muscle mass and function loss during atrophy and increases nonatrophying skeletal muscle mass and function. Endocrinology 2003, 144:4939-4946.
7. Morris C.A., Morris L.D., Kennedy A.R., Sweeney H.L. Attenuation of skeletal muscle atrophy via protease inhibition. J. Appl. Physiol. 2005, 99:1719-1727.
8. Jakubiec-Puka A., Catani C., Carraro U. Myosin heavy-chain composition in striated muscle after tenotomy. Biochem. J. 1992, 282(Pt 1):237-242.
9. Giger J.M., Bodell P.W., Zeng M., Baldwin K.M., Haddad F. Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin. J. Appl. Physiol. 2009, 107:1204-1212.
10. Eash J., Olsen A., Breur G., Gerrard D., Hannon K. FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension. BMC Musculoskelet. Disord. 2007, 8:32.
11. Lee S.J. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One 2007, 2:e789.
12. Cleasby M.E., Reinten T.A., Cooney G.J., James D.E., Kraegen E.W. Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol. Endocrinol. 2007, 21:215-228.
13. Bruusgaard J.C., Gundersen K. In vivo time-lapse microscopy reveals no loss of murine myonuclei during weeks of muscle atrophy. J. Clin. Invest. 2008, 118:1450-1457.
14. Li Y.P., Schwartz R.J., Waddell I.D., Holloway B.R., Reid M.B. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J. 1998, 12:871-880.
15. Clarke B.A., Drujan D., Willis M.S., Murphy L.O., Corpina R.A., Burova E., Rakhilin S.V., Stitt T.N., Patterson C., Latres E., Glass D.J. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 2007, 6:376-385.
16. Li W., Moylan J.S., Chambers M.A., Smith J., Reid M.B. Interleukin-1 stimulates catabolism in C2C12 myotubes. Am. J. Physiol. Cell Physiol. 2009, 297:C706-C714.
17. Aravamudan B., Mantilla C.B., Zhan W.Z., Sieck G.C. Denervation effects on myonuclear domain size of rat diaphragm fibers. J. Appl. Physiol. 2006, 100:1617-1622.
18. Wada K.I., Takahashi H., Katsuta S., Soya H. No decrease in myonuclear number after long-term denervation in mature mice. Am. J. Physiol. Cell Physiol. 2002, 283:C484-C488.
19. Zhong H., Roy R.R., Siengthai B., Edgerton V.R. Effects of inactivity on fiber size and myonuclear number in rat soleus muscle. J. Appl. Physiol. 2005, 99:1494-1499.
20. Kasper C.E., Xun L. Cytoplasm-to-myonucleus ratios in plantaris and soleus muscle fibres following hindlimb suspension. J. Muscle Res. Cell Motil. 1996, 17:603-610.
21. Hikida R.S., Van Nostran S., Murray J.D., Staron R.S., Gordon S.E., Kraemer W.J. Myonuclear loss in atrophied soleus muscle fibers. Anat. Rec. 1997, 247:350-354.
22. Roy R.R., Zhong H., Talmadge R.J., Bodine S.C., Fanton J.W., Koslovskaya I., Edgerton V.R. Size and myonuclear domains in Rhesus soleus muscle fibers: short-term spaceflight. J. Gravit. Physiol. 2001, 8:49-56.
23. Kasper C.E., Xun L. Cytoplasm-to-myonucleus ratios following microgravity. J. Muscle Res. Cell Motil. 1996, 17:595-602.
24. Allen D.L., Yasui W., Tanaka T., Ohira Y., Nagaoka S., Sekiguchi C., Hinds W.E., Roy R.R., Edgerton V.R. Myonuclear number and myosin heavy chain expression in rat soleus single muscle fibers after spaceflight. J. Appl. Physiol. 1996, 81:145-151.
25. Allen D.L., Monke S.R., Talmadge R.J., Roy R.R., Edgerton V.R. Plasticity of myonuclear number in hypertrophied and atrophied mammalian skeletal muscle fibers. J. Appl. Physiol. 1995, 78:1969-1976.
26. Oishi Y., Ogata T., Yamamoto K.I., Terada M., Ohira T., Ohira Y., Taniguchi K., Roy R.R. Cellular adaptations in soleus muscle during recovery after hindlimb unloading. Acta Physiol. (Oxf) 2008, 192:381-395.
27. Dupont-Versteegden E.E., Murphy R.J., Houle J.D., Gurley C.M., Peterson C.A. Mechanisms leading to restoration of muscle size with exercise and transplantation after spinal cord injury. Am. J. Physiol. Cell Physiol. 2000, 279:C1677-C1684.
28. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
29. Lee S.J., McPherron A.C. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9306-9311.
30. Philippou A., Halapas A., Maridaki M., Koutsilieris M. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J. Musculoskelet. Neuronal Interact. 2007, 7:208-218.
31. Anthony J.C., Anthony T.G., Layman D.K. Leucine supplementation enhances skeletal muscle recovery in rats following exercise. J. Nutr. 1999, 129:1102-1106.
32. Kelly R., Alonso S., Tajbakhsh S., Cossu G., Buckingham M. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J. Cell Biol. 1995, 129:383-396.
33. White R.B., Bierinx A.S., Gnocchi V.F., Zammit P.S. Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev. Biol. 2010, 10:21.
34. Zammit P.S., Heslop L., Hudon V., Rosenblatt J.D., Tajbakhsh S., Buckingham M.E., Beauchamp J.R., Partridge T.A. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp. Cell Res. 2002, 281:39-49.
35. Medina R., Wing S.S., Goldberg A.L. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem. J. 1995, 307(Pt 3):631-637.
36. Plant P.J., Bain J.R., Correa J.E., Woo M., Batt J. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy. J. Appl. Physiol. 2009, 107:224-234.
37. Stockholm D., Herasse M., Marchand S., Praud C., Roudaut C., Richard I., Sebille A., Beckmann J.S. Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. Am. J. Physiol. Cell Physiol. 2001, 280:C1561-C1569.
38. Tisdale M.J. Is there a common mechanism linking muscle wasting in various disease types?. Curr. Opin. Support. Palliat. Care 2007, 1:287-292.
39. Stein T.P., Bolster D.R. Insights into muscle atrophy and recovery pathway based on genetic models. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9:395-402.
40. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 2008, 23:160-170.
41. Glass D.J. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 2005, 37:1974-1984.
42. Daw C.K., Starnes J.W., White T.P. Muscle atrophy and hypoplasia with aging: impact of training and food restriction. J. Appl. Physiol. 1988, 64:2428-2432.
43. Borina E., Pellegrino M.A., D'Antona G., Bottinelli R. Myosin and actin content of human skeletal muscle fibers following 35days bed rest. Scand. J. Med. Sci. Sports 2010, 20:65-73.
44. Levine S., Biswas C., Dierov J., Barsotti R., Shrager J.B., Nguyen T., Sonnad S., Kucharchzuk J.C., Kaiser L.R., Singhal S., Budak M.T. Increased proteolysis myosin depletion and atrophic AKT-FOXO signaling in human diaphragm disuse. Am. J. Respir. Crit. Care Med. 2010, 183:483-490.
45. Acharyya S., Ladner K.J., Nelsen L.L., Damrauer J., Reiser P.J., Swoap S., Guttridge D.C. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 2004, 114:370-378.
46. Kaasik P., Umnova M., Pehme A., Alev K., Aru M., Selart A., Seene T. Ageing and dexamethasone associated sarcopenia: peculiarities of regeneration. J. Steroid Biochem. Mol. Biol. 2007, 105:85-90.
47. Cohen S., Brault J.J., Gygi S.P., Glass D.J., Valenzuela D.M., Gartner C., Latres E., Goldberg A.L. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation. J. Cell Biol. 2009, 185:1083-1095.
48. Haddad F., Roy R.R., Zhong H., Edgerton V.R., Baldwin K.M. Atrophy responses to muscle inactivity. I. Cellular markers of protein deficits. J. Appl. Physiol. 2003, 95:781-790.
49. Morrison P.R., Muller G.W., Booth F.W. Actin synthesis rate and mRNA level increase during early recovery of atrophied muscle. Am. J. Physiol. 1987, 253:C205-C209.
50. Allen D.L., Linderman J.K., Roy R.R., Bigbee A.J., Grindeland R.E., Mukku V., Edgerton V.R. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am. J. Physiol. 1997, 273:C579-C587.
51. Dupont-Versteegden E.E., Murphy R.J., Houle J.D., Gurley C.M., Peterson C.A. Activated satellite cells fail to restore myonuclear number in spinal cord transected and exercised rats. Am. J. Physiol. 1999, 277:C589-C597.
52. Gallegly J.C., Turesky N.A., Strotman B.A., Gurley C.M., Peterson C.A., Dupont-Versteegden E.E. Satellite cell regulation of muscle mass is altered at old age. J. Appl. Physiol. 2004, 97:1082-1090.
53. Dupont-Versteegden E.E. Apoptosis in skeletal muscle and its relevance to atrophy. World J. Gastroenterol. 2006, 12:7463-7466.
54. Oishi Y., Ishihara A., Yamamoto H., Miyamoto E. Hindlimb suspension induces the expression of multiple myosin heavy chain isoforms in single fibres of the rat soleus muscle. Acta Physiol. Scand. 1998, 162:127-134.
55. Petrella J.K., Kim J.S., Mayhew D.L., Cross J.M., Bamman M.M. Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J. Appl. Physiol. 2008, 104:1736-1742.
56. Hikida R.S., Staron R.S., Hagerman F.C., Walsh S., Kaiser E., Shell S., Hervey S. Effects of high-intensity resistance training on untrained older men. II. Muscle fiber characteristics and nucleo-cytoplasmic relationships. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55:B347-B354.
57. Kadi F., Thornell L.E. Concomitant increases in myonuclear and satellite cell content in female trapezius muscle following strength training. Histochem. Cell Biol. 2000, 113:99-103.
58. Roy R.R., Monke S.R., Allen D.L., Edgerton V.R. Modulation of myonuclear number in functionally overloaded and exercised rat plantaris fibers. J. Appl. Physiol. 1999, 87:634-642.
59. Kadi F., Eriksson A., Holmner S., Butler-Browne G.S., Thornell L.E. Cellular adaptation of the trapezius muscle in strength-trained athletes. Histochem. Cell Biol. 1999, 111:189-195.
60. Bruusgaard J.C., Johansen I.B., Egner I.M., Rana Z.A., Gundersen K. Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15111-15116.
61. van der Meer S.F., Jaspers R.T., Jones D.A., Degens H. The time course of myonuclear accretion during hypertrophy in young adult and older rat plantaris muscle. Ann. Anat. 2010, 193:56-63.
62. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotchenko E., Scrimgeour A., Lawrence J.C., Glass D.J., Yancopoulos G.D. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 2001, 3:1014-1019.
63. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
64. Ahtikoski A.M., Koskinen S.O., Virtanen P., Kovanen V., Risteli J., Takala T.E. Synthesis and degradation of type IV collagen in rat skeletal muscle during immobilization in shortened and lengthened positions. Acta. Physiol. Scand. 2003, 177:473-481.
65. Bey L., Akunuri N., Zhao P., Hoffman E.P., Hamilton D.G., Hamilton M.T. Patterns of global gene expression in rat skeletal muscle during unloading and low-intensity ambulatory activity. Physiol. Genomics 2003, 13:157-167.
66. Lecker S.H., Jagoe R.T., Gilbert A., Gomes M., Baracos V., Bailey J., Price S.R., Mitch W.E., Goldberg A.L. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004, 18:39-51.
67. Chen Y.W., Gregory C.M., Scarborough M.T., Shi R., Walter G.A., Vandenborne K. Transcriptional pathways associated with skeletal muscle disuse atrophy in humans. Physiol. Genomics 2007, 31:510-520.
68. Jones S.W., Hill R.J., Krasney P.A., O'Conner B., Peirce N., Greenhaff P.L. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J. 2004, 18:1025-1027.
69. Urso M.L., Scrimgeour A.G., Chen Y.W., Thompson P.D., Clarkson P.M. Analysis of human skeletal muscle after 48h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J. Appl. Physiol. 2006, 101:1136-1148.
70. Reich K.A., Chen Y.W., Thompson P.D., Hoffman E.P., Clarkson P.M. 48hours of unloading and 24hours of reloading leads to changes in global gene expression patterns related to ubiquitination and oxidative stress in humans. J. Appl. Physiol. 2010, 109:1404-1415.
71. Rodino-Klapac L.R., Haidet A.M., Kota J., Handy C., Kaspar B.K., Mendell J.R. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 2009, 39:283-296.
72. Taylor W.E., Bhasin S., Artaza J., Byhower F., Azam M., Willard D.H., Kull F.C., Gonzalez-Cadavid N. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E221-E228.
73. Ciarmela P., Wiater E., Smith S.M., Vale W. Presence, actions, and regulation of myostatin in rat uterus and myometrial cells. Endocrinology 2009, 150:906-914.
74. Amthor H., Otto A., Vulin A., Rochat A., Dumonceaux J., Garcia L., Mouisel E., Hourde C., Macharia R., Friedrichs M., Relaix F., Zammit P.S., Matsakas A., Patel K., Partridge T. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7479-7484.
75. Thomas M., Langley B., Berry C., Sharma M., Kirk S., Bass J., Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J. Biol. Chem. 2000, 275:40235-40243.
76. Langley B., Thomas M., Bishop A., Sharma M., Gilmour S., Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 2002, 277:49831-49840.
77. McCroskery S., Thomas M., Maxwell L., Sharma M., Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol. 2003, 162:1135-1147.
78. McCroskery S., Thomas M., Platt L., Hennebry A., Nishimura T., McLeay L., Sharma M., Kambadur R. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J. Cell Sci. 2005, 118:3531-3541.
79. Haidet A.M., Rizo L., Handy C., Umapathi P., Eagle A., Shilling C., Boue D., Martin P.T., Sahenk Z., Mendell J.R., Kaspar B.K. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:4318-4322.